Tenaya Therapeutics

(NASDAQ) TNYA

Current Price$0.73

Market Cap$167.54M

Since IPO (2021)-95%

5 YearN/A

1 Year+35%

1 Month-8%

Tenaya Therapeutics Financials at a Glance

Market Cap

$167.54M

Revenue (TTM)

$225.00K

Net Income (TTM)

-$83.01M

EPS (TTM)

-$0.47

P/E Ratio

-1.64

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.73

Volume

35,282

Open

$0.74

Price

$0.73

Volume

35,282

Open

$0.74

Previous Close

$0.73

Daily Range

$0.71 - $0.74

52-Week Range

$0.53 - $2.35

Estimated Earnings Date

May 13, 2026

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.73

Volume

35,282

Open

$0.74

Previous Close

$0.73

Daily Range

$0.71 - $0.74

52-Week Range

$0.53 - $2.35

Estimated Earnings Date

May 13, 2026

TNYA News

Tenaya (TNYA) Q2 Loss Narrows 59%

Motley Fool Markets TeamAug 7, 2025

Why This Nasdaq Stock Caught Fire This Week

George Budwell, PhDApr 20, 2023

TNYA: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Tenaya Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Faraz Ali, MBA

Website

www.tenayatherapeutics.com

Headquarters

South San Francisco, CA 94080, US

TNYA Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

-382%

Net Income Margin

-369%

Return on Equity

-74%

Return on Capital

-73%

Return on Assets

-61%

Earnings Yield

-60.98%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$167.54M

Shares Outstanding

217.00M

Volume

35.28K

Avg. Volume

4.69M

Financials (TTM)

Gross Profit

-$8.44M

Operating Income

-$93.33M

EBITDA

-$84.90M

Operating Cash Flow

-$68.26M

Capital Expenditure

-$618.00K

Free Cash Flow

-$68.88M

Cash & ST Invst.

$100.55M

Total Debt

$10.83M

Tenaya Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$225.00K

N/A

Gross Profit

-$1.54M

N/A

Gross Margin

-6.84%

N/A

Market Cap

$167.54M

N/A

Market Cap/Employee

$1.73M

N/A

Employees

N/A

Net Income

-$19.27M

+28.3%

EBITDA

-$18.30M

+26.4%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$70.77M

-5.9%

Accounts Receivable

$10.63M

N/A

Inventory

$0.00

N/A

Long Term Debt

$7.00M

-30.8%

Short Term Debt

$3.12M

+11.5%

Return on Assets

-61.45%

N/A

Return on Invested Capital

-72.58%

N/A

Free Cash Flow

-$19.25M

+18.1%

Operating Cash Flow

-$19.23M

+16.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

IMRXImmuneering Corporation

IMRXImmuneering Corporation$4.27-4.69%

CRBUCaribou Biosciences, Inc.

CRBUCaribou Biosciences, Inc.$1.92-7.02%

VYGRVoyager Therapeutics, Inc.

VYGRVoyager Therapeutics, Inc.$3.33-8.01%

PRLDPrelude Therapeutics Incorporated

PRLDPrelude Therapeutics Incorporated$3.81-6.62%

FHTXFoghorn Therapeutics Inc.

FHTXFoghorn Therapeutics Inc.$3.73-0.27%

PYXSPyxis Oncology, Inc.

PYXSPyxis Oncology, Inc.$1.78+4.09%

HUMAHumacyte, Inc.

HUMAHumacyte, Inc.$1.35-9.40%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$14.38-0.13%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$73.05-0.14%

KEELKeel Infrastructure

KEELKeel Infrastructure$5.13-0.13%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$43.19+0.14%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$34.14-0.05%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.50+0.02%

QQQInvesco QQQ Trust

QQQInvesco QQQ Trust$705.06-0.05%

Questions About TNYA

What is the current price of Tenaya Therapeutics?

Tenaya Therapeutics is trading at $0.73 per share.

What is the 52-week range for Tenaya Therapeutics?

Over the past 52 weeks, Tenaya Therapeutics has traded between $0.53 and $2.35.

How much debt does Tenaya Therapeutics have?

As of the most recent reporting period, Tenaya Therapeutics reported total debt of $10.12M.

How much cash does Tenaya Therapeutics have on hand?

Tenaya Therapeutics reported $80.89M in cash and cash equivalents in its most recent financial results.

What is Tenaya Therapeutics’s dividend yield?

Tenaya Therapeutics does not currently have a dividend yield.

Tenaya Therapeutics

Tenaya Therapeutics Financials at a Glance

TNYA News

Tenaya (TNYA) Q2 Loss Narrows 59%

Why This Nasdaq Stock Caught Fire This Week

TNYA: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Tenaya Therapeutics

TNYA Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Tenaya Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About TNYA

What is the current price of Tenaya Therapeutics?

What is the 52-week range for Tenaya Therapeutics?

How much debt does Tenaya Therapeutics have?

How much cash does Tenaya Therapeutics have on hand?

What is Tenaya Therapeutics’s dividend yield?

Premium Investing Services